Prevalence of obesity and extreme obesity in children aged 3-5 years

J C Lo1, B Maring, M Chandra

  • 1Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA; Department of Medicine, Kaiser Permanente Oakland Medical Center, Oakland, CA, USA.

Pediatric Obesity
|May 17, 2013
PubMed

Insights

Early childhood obesity is prevalent in preschool-aged children, with higher rates in boys and Hispanic children. Early recognition and intervention are crucial for effective weight management strategies.

Area of Science:

  • Pediatric Health
  • Public Health
  • Epidemiology

Background:

  • Early childhood adiposity is linked to significant long-term health consequences.
  • This study investigates the prevalence and identification of obesity and severe obesity in preschool-aged children.

Purpose of the Study:

  • To determine the prevalence of obesity and severe obesity in children aged 3-5 years.
  • To examine racial/ethnic and sex-based differences in obesity prevalence.
  • To assess provider recognition of elevated Body Mass Index (BMI) in obese 5-year-olds.

Main Methods:

  • Utilized electronic medical records for 42,559 children aged 3-5 years (2007-2010).
  • Classified weight status using 2000 CDC growth charts: normal/underweight (<85th percentile), overweight (85th-94th), obesity (≥95th), severe obesity (≥1.2 × 95th).
  • Analyzed BMI, height, sex, and race/ethnicity; examined provider diagnosis for obese 5-year-olds.

Main Results:

  • Overall obesity prevalence was 12.4% for boys and 10.0% for girls.
  • Hispanic children showed the highest prevalence of obesity (18.2% boys, 15.2% girls) and severe obesity (3.3% in boys).
  • Provider diagnosis was recorded for 77.9% of obese 5-year-olds, rising to 89.0% for those with severe obesity.

Conclusions:

  • Obesity and severe obesity are present in children as young as 3-5 years.
  • Observed race/ethnic trends in early childhood obesity mirror those in older populations.
  • Highlights the necessity for early identification and tailored strategies for childhood weight management.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health condition at a...
Binge Eating Disorders01:23

Binge Eating Disorders

Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...